Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Aarey Drugs & Pharmaceuticals Ltd.

Feb 21 BSE 41.84 ( -0.64 -1.51%)

Volume4741

Prev. Close
42.48

Open Price
43.32

Today's Low / High

40.70 43.50

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

37.00 75.75

Feb 21 NSE 41.73( -0.74 -1.74%)

Volume15737

Prev. Close
42.47

Open Price
43.01

Today's Low / High

40.65 43.55

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

37.35 74.80

Standalone

(₹ in Crs.)

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	395.62	418.96	492.68	348.42	300.09
Total Operating Revenues	395.62	418.96	492.68	348.42	300.09

Other Income	6.96	2.73	2.75	7.01	6.69
Total Revenue	402.58	421.69	495.43	355.43	306.78

EXPENSES
Purchase Of Stock-In Trade	387.76	418.98	467.29	339.25	285.93
Changes In Inventories Of FG,WIP And Stock-In Trade	-5.86	-15.14	4.78	-1.46	4.25
Employee Benefit Expenses	0.72	0.81	0.98	0.40	0.40
Finance Costs	4.38	2.87	2.00	2.43	1.79
Depreciation And Amortisation Expenses	1.70	1.57	1.99	0.92	0.89
Other Expenses	8.55	6.58	8.37	5.59	6.28
Total Expenses	397.24	415.68	485.40	347.13	299.54

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5.34	6.01	10.03	8.30	7.24

Profit/Loss Before Tax	5.34	6.01	10.03	8.30	7.24

Tax Expenses-Continued Operations
Current Tax	1.32	1.78	2.61	1.66	1.50
Deferred Tax	-0.67	-0.04	-0.11	0.12	-0.05
Tax For Earlier Years	0.00	0.50	0.98	0.00	0.00
Total Tax Expenses	0.66	2.24	3.48	1.79	1.45
Profit/Loss After Tax And Before ExtraOrdinary Items	4.68	3.77	6.54	6.51	5.79

Profit/Loss From Continuing Operations	4.68	3.77	6.54	6.51	5.79

Profit/Loss For The Period	4.68	3.77	6.54	6.51	5.79

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	1.67	1.49	2.72	2.79	2.48
Diluted EPS (Rs.)	1.67	1.49	2.72	2.79	2.80

Particulars	Mar 24
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	395.62
Total Operating Revenues	395.62
Other Income	6.96
Total Revenue	402.58
EXPENSES
Purchase Of Stock-In Trade	387.76
Changes In Inventories Of FG,WIP And Stock-In Trade	-5.86
Employee Benefit Expenses	0.72
Finance Costs	4.38
Depreciation And Amortisation Expenses	1.70
Other Expenses	8.55
Total Expenses	397.24
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5.34
Profit/Loss Before Tax	5.34
Tax Expenses-Continued Operations
Current Tax	1.32
Deferred Tax	-0.67
Tax For Earlier Years	0.00
Total Tax Expenses	0.66
Profit/Loss After Tax And Before ExtraOrdinary Items	4.68
Profit/Loss From Continuing Operations	4.68
Profit/Loss For The Period	4.68
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	1.67
Diluted EPS (Rs.)	1.67